Global Pneumococcal Conjugate Vaccine(PCV) Market Growth 2020-2025
Apr, 2020
|
Report ID: 121270
|
135
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Pneumococcal Conjugate Vaccine(PCV) market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pneumococcal Conjugate Vaccine(PCV) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Conjugate Vaccine(PCV) market by type, application, key manufacturers and key regions and countries.
This study considers the Pneumococcal Conjugate Vaccine(PCV) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
PCV13
PCV10
PCV7
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Pfizer
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pneumococcal Conjugate Vaccine(PCV) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pneumococcal Conjugate Vaccine(PCV) market by identifying its various subsegments.
Focuses on the key global Pneumococcal Conjugate Vaccine(PCV) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pneumococcal Conjugate Vaccine(PCV) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pneumococcal Conjugate Vaccine(PCV) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Conjugate Vaccine(PCV) market by type, application, key manufacturers and key regions and countries.
This study considers the Pneumococcal Conjugate Vaccine(PCV) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
PCV13
PCV10
PCV7
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Pfizer
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pneumococcal Conjugate Vaccine(PCV) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pneumococcal Conjugate Vaccine(PCV) market by identifying its various subsegments.
Focuses on the key global Pneumococcal Conjugate Vaccine(PCV) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pneumococcal Conjugate Vaccine(PCV) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pneumococcal Conjugate Vaccine(PCV) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2025
2.1.2 Pneumococcal Conjugate Vaccine(PCV) Consumption CAGR by Region
2.2 Pneumococcal Conjugate Vaccine(PCV) Segment by Type
2.2.1 PCV13
2.2.2 PCV10
2.2.3 PCV7
2.3 Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
2.3.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
2.3.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Type (2015-2020)
2.4 Pneumococcal Conjugate Vaccine(PCV) Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
2.5.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
2.5.2 Global Pneumococcal Conjugate Vaccine(PCV) Value and Market Share by Type (2015-2020)
2.5.3 Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Type (2015-2020)
3 Global Pneumococcal Conjugate Vaccine(PCV) by Company
3.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company
3.1.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2018-2020)
3.1.2 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2018-2020)
3.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company
3.2.1 Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Company (2018-2020)
3.2.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company (2018-2020)
3.3 Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Company
3.4 Global Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pneumococcal Conjugate Vaccine(PCV) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pneumococcal Conjugate Vaccine(PCV) by Regions
4.1 Pneumococcal Conjugate Vaccine(PCV) by Regions
4.2 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
4.3 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
4.4 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
4.5 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
5 Americas
5.1 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries
5.1.1 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020)
5.1.2 Americas Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020)
5.2 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
5.3 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Regions
6.1.1 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Regions (2015-2020)
6.1.2 APAC Pneumococcal Conjugate Vaccine(PCV) Value by Regions (2015-2020)
6.2 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
6.3 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pneumococcal Conjugate Vaccine(PCV) by Countries
7.1.1 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020)
7.1.2 Europe Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020)
7.2 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
7.3 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) by Countries
8.1.1 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020)
8.2 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
8.3 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pneumococcal Conjugate Vaccine(PCV) Distributors
10.3 Pneumococcal Conjugate Vaccine(PCV) Customer
11 Global Pneumococcal Conjugate Vaccine(PCV) Market Forecast
11.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast (2021-2025)
11.2 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Regions
11.2.1 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Regions (2021-2025)
11.2.2 Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Type
11.8 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Information
12.1.2 Pneumococcal Conjugate Vaccine(PCV) Product Offered
12.1.3 GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Pfizer
12.2.1 Company Information
12.2.2 Pneumococcal Conjugate Vaccine(PCV) Product Offered
12.2.3 Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer Latest Developments
...
13 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2025
2.1.2 Pneumococcal Conjugate Vaccine(PCV) Consumption CAGR by Region
2.2 Pneumococcal Conjugate Vaccine(PCV) Segment by Type
2.2.1 PCV13
2.2.2 PCV10
2.2.3 PCV7
2.3 Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
2.3.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
2.3.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Type (2015-2020)
2.4 Pneumococcal Conjugate Vaccine(PCV) Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
2.5.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
2.5.2 Global Pneumococcal Conjugate Vaccine(PCV) Value and Market Share by Type (2015-2020)
2.5.3 Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Type (2015-2020)
3 Global Pneumococcal Conjugate Vaccine(PCV) by Company
3.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company
3.1.1 Global Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2018-2020)
3.1.2 Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2018-2020)
3.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company
3.2.1 Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Company (2018-2020)
3.2.2 Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company (2018-2020)
3.3 Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Company
3.4 Global Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Pneumococcal Conjugate Vaccine(PCV) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pneumococcal Conjugate Vaccine(PCV) by Regions
4.1 Pneumococcal Conjugate Vaccine(PCV) by Regions
4.2 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
4.3 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
4.4 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
4.5 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Growth
5 Americas
5.1 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries
5.1.1 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020)
5.1.2 Americas Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020)
5.2 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
5.3 Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Regions
6.1.1 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Regions (2015-2020)
6.1.2 APAC Pneumococcal Conjugate Vaccine(PCV) Value by Regions (2015-2020)
6.2 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
6.3 APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pneumococcal Conjugate Vaccine(PCV) by Countries
7.1.1 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020)
7.1.2 Europe Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020)
7.2 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
7.3 Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) by Countries
8.1.1 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020)
8.2 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Type
8.3 Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pneumococcal Conjugate Vaccine(PCV) Distributors
10.3 Pneumococcal Conjugate Vaccine(PCV) Customer
11 Global Pneumococcal Conjugate Vaccine(PCV) Market Forecast
11.1 Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast (2021-2025)
11.2 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Regions
11.2.1 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Regions (2021-2025)
11.2.2 Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Type
11.8 Global Pneumococcal Conjugate Vaccine(PCV) Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Information
12.1.2 Pneumococcal Conjugate Vaccine(PCV) Product Offered
12.1.3 GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Pfizer
12.2.1 Company Information
12.2.2 Pneumococcal Conjugate Vaccine(PCV) Product Offered
12.2.3 Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Pneumococcal Conjugate Vaccine(PCV) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of PCV13
Table 5. Major Players of PCV10
Table 6. Major Players of PCV7
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 9. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Type (2015-2020) ($ million)
Table 10. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 14. Global Pneumococcal Conjugate Vaccine(PCV) Value by Application (2015-2020)
Table 15. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Application (2015-2020)
Table 16. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Application (2015-2020)
Table 17. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2017-2019) (K Units)
Table 18. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2017-2019)
Table 19. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company (2017-2019)
Table 21. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Company (2017-2019)
Table 22. Global Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Pneumococcal Conjugate Vaccine(PCV) Products Offered
Table 24. Pneumococcal Conjugate Vaccine(PCV) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Pneumococcal Conjugate Vaccine(PCV) Consumption by Regions 2015-2020 (K Units)
Table 26. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Regions 2015-2020
Table 27. Global Pneumococcal Conjugate Vaccine(PCV) Value by Regions 2015-2020 ($ Millions)
Table 28. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions 2015-2020
Table 29. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 31. Americas Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries (2015-2020)
Table 33. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 34. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 35. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 36. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 37. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 39. APAC Pneumococcal Conjugate Vaccine(PCV) Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions (2015-2020)
Table 41. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 42. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 43. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 44. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 45. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 47. Europe Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries (2015-2020)
Table 49. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 50. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 51. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 52. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 61. Pneumococcal Conjugate Vaccine(PCV) Distributors List
Table 62. Pneumococcal Conjugate Vaccine(PCV) Customer List
Table 63. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Forecast by Regions
Table 65. Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share Forecast by Regions
Table 67. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share Forecast by Type (2021-2025)
Table 71. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share Forecast by Application (2021-2025)
Table 75. GlaxoSmithKline Product Offered
Table 76. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Product Offered
Table 81. Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Pfizer Basic Information, Company Total Revenue (in $ million), Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Pneumococcal Conjugate Vaccine(PCV)
Figure 2. Pneumococcal Conjugate Vaccine(PCV) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Pneumococcal Conjugate Vaccine(PCV) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of PCV13
Figure 7. Product Picture of PCV10
Figure 8. Product Picture of PCV7
Figure 9. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Figure 10. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Type (2015-2020)
Figure 11. Pneumococcal Conjugate Vaccine(PCV) Consumed in Child
Figure 12. Global Pneumococcal Conjugate Vaccine(PCV) Market: Child (2015-2020) (K Units)
Figure 13. Global Pneumococcal Conjugate Vaccine(PCV) Market: Child (2015-2020) ($ Millions)
Figure 14. Pneumococcal Conjugate Vaccine(PCV) Consumed in Adult
Figure 15. Global Pneumococcal Conjugate Vaccine(PCV) Market: Adult (2015-2020) (K Units)
Figure 16. Global Pneumococcal Conjugate Vaccine(PCV) Market: Adult (2015-2020) ($ Millions)
Figure 17. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Figure 18. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Application (2015-2020)
Figure 19. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company in 2017
Figure 20. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company in 2019
Figure 21. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company in 2017
Figure 22. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company in 2019
Figure 23. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Company in 2019
Figure 24. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Regions 2015-2020
Figure 25. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions 2015-2020
Figure 26. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 27. Americas Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 28. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 29. APAC Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 30. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 31. Europe Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 33. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 34. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 35. Americas Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries in 2019
Figure 36. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 37. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 38. United States Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 39. United States Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 41. Canada Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 43. Mexico Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 45. APAC Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions in 2019
Figure 46. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 47. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 48. China Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 49. China Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 51. Japan Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 53. Korea Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 55. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 56. India Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 57. India Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 59. Australia Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 61. Europe Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries in 2019
Figure 62. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 63. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 64. Germany Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 65. Germany Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 66. France Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 67. France Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 68. UK Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 69. UK Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 71. Italy Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 73. Russia Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 78. Egypt Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 79. Egypt Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 81. South Africa Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 83. Israel Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 85. Turkey Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 87. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 88. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 89. Global Pneumococcal Conjugate Vaccine(PCV) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 91. Americas Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 92. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 93. APAC Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 94. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 95. Europe Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 97. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 98. United States Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 99. United States Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 100. Canada Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 101. Canada Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 102. Mexico Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 103. Mexico Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 104. Brazil Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 105. Brazil Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 106. China Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 107. China Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 108. Japan Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 109. Japan Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 110. Korea Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 111. Korea Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 113. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 114. India Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 115. India Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 116. Australia Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 117. Australia Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 118. Germany Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 119. Germany Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 120. France Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 121. France Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 122. UK Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 123. UK Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 124. Italy Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 125. Italy Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 126. Russia Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 127. Russia Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 128. Spain Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 129. Spain Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 130. Egypt Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 131. Egypt Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 132. South Africa Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 133. South Africa Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 134. Israel Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 135. Israel Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 136. Turkey Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 137. Turkey Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 139. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 140. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Market Share (2018-2020)
Figure 141. Pfizer Pneumococcal Conjugate Vaccine(PCV) Market Share (2018-2020)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Pneumococcal Conjugate Vaccine(PCV) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of PCV13
Table 5. Major Players of PCV10
Table 6. Major Players of PCV7
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 9. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Type (2015-2020) ($ million)
Table 10. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 14. Global Pneumococcal Conjugate Vaccine(PCV) Value by Application (2015-2020)
Table 15. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Application (2015-2020)
Table 16. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Application (2015-2020)
Table 17. Global Pneumococcal Conjugate Vaccine(PCV) Sales by Company (2017-2019) (K Units)
Table 18. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company (2017-2019)
Table 19. Global Pneumococcal Conjugate Vaccine(PCV) Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company (2017-2019)
Table 21. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Company (2017-2019)
Table 22. Global Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Pneumococcal Conjugate Vaccine(PCV) Products Offered
Table 24. Pneumococcal Conjugate Vaccine(PCV) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Pneumococcal Conjugate Vaccine(PCV) Consumption by Regions 2015-2020 (K Units)
Table 26. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Regions 2015-2020
Table 27. Global Pneumococcal Conjugate Vaccine(PCV) Value by Regions 2015-2020 ($ Millions)
Table 28. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions 2015-2020
Table 29. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 31. Americas Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries (2015-2020)
Table 33. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 34. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 35. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 36. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 37. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 39. APAC Pneumococcal Conjugate Vaccine(PCV) Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions (2015-2020)
Table 41. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 42. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 43. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 44. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 45. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 47. Europe Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries (2015-2020)
Table 49. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 50. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 51. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 52. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Table 61. Pneumococcal Conjugate Vaccine(PCV) Distributors List
Table 62. Pneumococcal Conjugate Vaccine(PCV) Customer List
Table 63. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Forecast by Regions
Table 65. Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share Forecast by Regions
Table 67. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share Forecast by Type (2021-2025)
Table 71. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Pneumococcal Conjugate Vaccine(PCV) Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share Forecast by Application (2021-2025)
Table 75. GlaxoSmithKline Product Offered
Table 76. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Product Offered
Table 81. Pfizer Pneumococcal Conjugate Vaccine(PCV) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Pfizer Basic Information, Company Total Revenue (in $ million), Pneumococcal Conjugate Vaccine(PCV) Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Pneumococcal Conjugate Vaccine(PCV)
Figure 2. Pneumococcal Conjugate Vaccine(PCV) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Pneumococcal Conjugate Vaccine(PCV) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of PCV13
Figure 7. Product Picture of PCV10
Figure 8. Product Picture of PCV7
Figure 9. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type (2015-2020)
Figure 10. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Type (2015-2020)
Figure 11. Pneumococcal Conjugate Vaccine(PCV) Consumed in Child
Figure 12. Global Pneumococcal Conjugate Vaccine(PCV) Market: Child (2015-2020) (K Units)
Figure 13. Global Pneumococcal Conjugate Vaccine(PCV) Market: Child (2015-2020) ($ Millions)
Figure 14. Pneumococcal Conjugate Vaccine(PCV) Consumed in Adult
Figure 15. Global Pneumococcal Conjugate Vaccine(PCV) Market: Adult (2015-2020) (K Units)
Figure 16. Global Pneumococcal Conjugate Vaccine(PCV) Market: Adult (2015-2020) ($ Millions)
Figure 17. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application (2015-2020)
Figure 18. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Application (2015-2020)
Figure 19. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company in 2017
Figure 20. Global Pneumococcal Conjugate Vaccine(PCV) Sales Market Share by Company in 2019
Figure 21. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company in 2017
Figure 22. Global Pneumococcal Conjugate Vaccine(PCV) Revenue Market Share by Company in 2019
Figure 23. Global Pneumococcal Conjugate Vaccine(PCV) Sale Price by Company in 2019
Figure 24. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Regions 2015-2020
Figure 25. Global Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions 2015-2020
Figure 26. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 27. Americas Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 28. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 29. APAC Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 30. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 31. Europe Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption 2015-2020 (K Units)
Figure 33. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value 2015-2020 ($ Millions)
Figure 34. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 35. Americas Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries in 2019
Figure 36. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 37. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 38. United States Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 39. United States Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 41. Canada Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 43. Mexico Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 45. APAC Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Regions in 2019
Figure 46. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 47. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 48. China Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 49. China Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 51. Japan Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 53. Korea Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 55. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 56. India Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 57. India Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 59. Australia Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 61. Europe Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries in 2019
Figure 62. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 63. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 64. Germany Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 65. Germany Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 66. France Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 67. France Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 68. UK Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 69. UK Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 71. Italy Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 73. Russia Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Market Share by Application in 2019
Figure 78. Egypt Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 79. Egypt Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 81. South Africa Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 83. Israel Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 85. Turkey Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Consumption Growth 2015-2020 (K Units)
Figure 87. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Value Growth 2015-2020 ($ Millions)
Figure 88. Global Pneumococcal Conjugate Vaccine(PCV) Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 89. Global Pneumococcal Conjugate Vaccine(PCV) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 91. Americas Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 92. APAC Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 93. APAC Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 94. Europe Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 95. Europe Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 97. Middle East & Africa Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 98. United States Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 99. United States Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 100. Canada Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 101. Canada Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 102. Mexico Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 103. Mexico Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 104. Brazil Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 105. Brazil Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 106. China Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 107. China Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 108. Japan Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 109. Japan Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 110. Korea Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 111. Korea Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 113. Southeast Asia Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 114. India Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 115. India Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 116. Australia Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 117. Australia Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 118. Germany Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 119. Germany Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 120. France Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 121. France Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 122. UK Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 123. UK Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 124. Italy Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 125. Italy Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 126. Russia Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 127. Russia Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 128. Spain Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 129. Spain Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 130. Egypt Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 131. Egypt Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 132. South Africa Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 133. South Africa Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 134. Israel Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 135. Israel Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 136. Turkey Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 137. Turkey Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Consumption 2021-2025 (K Units)
Figure 139. GCC Countries Pneumococcal Conjugate Vaccine(PCV) Value 2021-2025 ($ Millions)
Figure 140. GlaxoSmithKline Pneumococcal Conjugate Vaccine(PCV) Market Share (2018-2020)
Figure 141. Pfizer Pneumococcal Conjugate Vaccine(PCV) Market Share (2018-2020)
